-+ 0.00%
-+ 0.00%
-+ 0.00%

Wave Life Sciences plans US redomiciliation, shifts parent company to Delaware

PUBT·04/15/2026 20:01:24
Listen to the news
Wave Life Sciences plans US redomiciliation, shifts parent company to Delaware
  • Wave Life Sciences unveiled plan to redomicile parent company from Singapore to United States, forming Wave Life Sciences, Inc. as Delaware corporation.
  • Transaction would exchange existing ordinary shares one-for-one into common stock of new Delaware parent.
  • Nasdaq listing would continue under ticker WVE.
  • Completion requires shareholder vote plus Singapore High Court clearance, with closing targeted for mid-2026.
  • Move aims to align domicile with US-based headquarters, operations, assets, workforce, reducing dual reporting, regulatory, legal, compliance costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604151601PRIMZONEFULLFEED9690608) on April 15, 2026, and is solely responsible for the information contained therein.